145
Wu Xu#, Bao L#, Hu Z, Yao D, Li F, Li H, Xu X, An Y, Wang X, Cao B*, Zhang X*. Ficolin A exacerbates severe H1N1 influenza virus infection-induced acute lung immunopathological injury via excessive complement activation. Cell Mol Immunol. 2021 Sep;18(9):2278-2280. doi: 10.1038/s41423-021-00737-1. Epub 2021 Jul 23.
146
Duan S#, Gu X, Fan G, Zhou F, Zhu G, Cao B*. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections. BMC Pulm Med. 2021 Sep 28;21(1):308. doi: 10.1186/s12890-021-01672-7.
147
Wang C#, Zhao J#, Liu Z#, Sun A#, Sun L, Li B, Lu B, Liu Y, Cao B*. In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase. Front Microbiol. 2021 Sep 23;12:727946. doi: 10.3389/fmicb.2021.727946. eCollection 2021.
148
Ren L#, Wang Y#,, Zhong J#,, Li X, Xiao Y, Li J, Yang J, Fan G, Guo L, Shen Z, Kang L, Shi L, Li Q, Li J, Di L, Li H, Wang C, Wang Y, Wang X, Zou X, Rao J, Zhang L, Wang J, Huang Y, Cao B*, Wang J*, Li M*. Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1379-1390. doi: 10.1164/rccm.202103-0814OC.
149
Yang T#, Chen R#, Gu X#, Xu J, Yang L, Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, Huang K, Chen Y, Sun T, Shan G, Lin Y, Wu S, Zhu J, Wang R, Shi Z, Xu Y, Ye X, Song Y, Wang Q, Zhou Y, Ding L, Yang T, Yao W, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Wang Z, Zhang H, Bu X, Zhang X, An L, Zhang S, Cao Z, Zhan Q, Yang Y, Liang L, Cao B, Dai H, van Donkelaar A, Martin RV, Wu T, He J, Kan H*, Wang C*. Association of fine particulate matter air pollution and its constituents with lung function: The China Pulmonary Health study. Environ Int. 2021 Nov;156:106707. doi: 10.1016/j.envint.2021.106707. Epub 2021 Jun 26.
150
Huang L#, Gu X, Cao B*. Long-term effects on survivors with COVID-19 reply. Lancet. 2021 Nov 20;398(10314):1872-1873. doi: 10.1016/S0140-6736(21)02324-2.
151
Suo L#, Yu X#, Hu Y#, Cao H#, Zou X, Wang P, Xu T, Zhou X, Wu Y, Ren L*, Liu B*, Cao B*. Sirolimus Combined with Oseltamivir and Corticosteroid Treatment for a Puerpera with Severe Pneumonia Caused by 2009 Pandemic H1N1:A Case Report. Biosaf Health. 2021 Dec;3(6):343-350. doi: 10.1016/j.bsheal.2021.11.003. Epub 2021 Nov 14.
152
Yin H#, Gu X, Wang Y, Fan G, Lu B, Liu M, Wang C, Cao B*, Wang C*. Clinical characteristics of patients with bronchiectasis with nontuberculous mycobacterial disease in Mainland China: a single center cross-sectional study. BMC Infect Dis. 2021 Dec 6;21(1):1216. doi: 10.1186/s12879-021-06917-8.
153
Feng X#, Liu S, Wang Y, Zhang Y, Sun , Li H, Wang C, Liu Y*, Cao B*. Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria. Front Microbiol. 2021 Jun 25;12:676414. doi: 10.3389/fmicb.2021.676414. eCollection 2021.
154
Du S# , Wu X#, Li B#, Wang Y#, Shang L#, Huang X, Xia Y, Yu D, Lu N, Liu Z, Wang C, Liu X, Xiong Z, Zou X, Lu B, Liu Y, Zhan Q, Cao B. Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia. Front Med .2021 Jul 24;1-14. doi: 10.1007/s11684-021-0856-3. Online ahead of print.
155
Wang G#, Wang Q#, Wang Y#, Liu C#, Wang L#, Chen H#, Jiao T, Hu C, Lei X, Guo L, Ren L, Li M , Zhao Y, Zeng X, Zhang D, Cao B*, Wang J*. Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study. frontiersin in Immunology. published: 20 December 2021 doi: 10.3389/fimmu.2021.791348
156
Mu S#, Hu L#, Zhang Y#, Liu Y#, Cui X#, Zou X#, Wang Y, Lu B, Zhou S, Liang X, Liang C, Nick Xiao, Justin O'Grady, Shela Lee*, Cao B*. Prospective Evaluation of a Rapid Clinical Metagenomics Test for Bacterial Pneumonia. Front Cell Infect Microbiol.2021 Oct 19;11:684965. doi: 10.3389/fcimb.2021.684965. eCollection 2021.
157
Sun L#, Li L, Du S, Liu Y, Cao B*. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. Eur J Clin Microbiol Infect Dis. 2021 May 1. doi: 10.1007/s10096-021-04259-6. Online ahead of print.
158
Li H#, Cui X, Sun L, Deng X, Liu S, Zou X, Li B, Wang C, Wang Y, Liu Y, Lu B*, Cao B*. High concentration of Cas12a effector tolerates more mismatches on ssDNA. FASEB J. 2021 Jan;35(1):e21153. doi: 10.1096/fj.202001475R. Epub 2020 Nov 6.
159
Guo L#, Wang Y#, Kang L#, Hu Y#, Wang L#, Zhong J#, Chen H#, Ren L, Gu X, Wang G, Wang C, Dong X, Wu C, Han L, Wang Y, Fan G, Zou X, Li H, Xu J, Jin Q, Cao B*, Wang J*. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec;10(1):664-676. doi: 10.1080/22221751.2021.1905488.
160
Jiang R#, Han B, Dou C, Zhou F, Cao B*, Li X*. Analysis of antibiotic usage for viral community-acquired pneumonia in adults. Front Med. 2021 Feb;15(1):139-143. doi: 10.1007/s11684-019-0736-2. Epub 2020 Jun 13.
